Novartis Gene Therapies - Company Profile
Powered by
All the data and insights you need on Novartis Gene Therapies in one report.
$295
- Save hours of research time and resources with
our up-to-date Novartis Gene Therapies Strategy Report
- Understand Novartis Gene Therapies position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Novartis Gene Therapies patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
US20220001028A1 | Application | Aav viral vectors and uses thereof | C12N15/86; C12N2750/14143; A61K48/005; C07K14/4702 | January 06, 2022 |
US20210317474A1 | Application | Means and method for producing and purifying viral vectors | C12N15/1137; C12N15/64; C12N15/86; C12N2750/14143; C12N2750/14151; C12Y115/01001; A61K2039/5256; A61K39/12; A61K48/00; A61K48/0091; A61K9/0019; A61P25/28; C07K14/47 | October 14, 2021 |
US20210255185A1 | Application | Cell-based assay for measuring drug product potency | C12N15/52; C12N15/63; C12N15/86; C12N15/87; C12N2501/11; C12N2501/115; C12N2750/14143; C12N5/0619; C12Q1/701; A61K48/00; A61K48/005; G01N1/30; G01N33/56966 | August 19, 2021 |
CL20202020001193A1 | Application | Medios y método para preparar vectores virales y usos de los mismos. | A61K2039/5256; A61K39/12; A61K47/02; A61K47/10; A61K48/00; A61K48/0091; A61K9/0019; A61K9/08; A61P21/00; A61P25/28; C07K14/47; C12N15/1137; C12N15/64; C12N15/86; C12N2750/14141; C12N2750/14143; C12N2750/14151; C12Y115/01001 | November 13, 2020 |
MX2020004830A | Application | Medios y metodo para preparar vectores virales y usos de los mismos. | A61K2039/5256; A61K39/12; A61K47/02; A61K47/10; A61K48/00; A61K48/0091; A61K9/0019; A61K9/08; A61P21/00; A61P25/28; C07K14/47; C12N15/1137; C12N15/64; C12N15/86; C12N2750/14141; C12N2750/14143; C12N2750/14151; C12Y115/01001 | November 11, 2020 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer